EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target

Jing Yang, Yang Peng, Yan Ding, Yueping Liu, Yuxiang Wang, Yan Liu, Congrong Liu

Modern Pathology · 2024-10 · 37 (10) · 100569

DOI: 10.1016/j.modpat.2024.100569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-10. Verfasst von Jing Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Claudins, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hunan Provincial Natural Science Foundation, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endocervical gastric-type adenocarcinoma (GAS) is an aggressive type of endocervical mucinous adenocarcinoma characterized as being unrelated to human papillomavirus (HPV) and resistant to chemo/radiotherapy. In this study, we investigated the histology, immunohistochemistry patterns, and molecular characteristics in a large cohort of GAS (n = 62). Histologically, the majority of GAS cases exhibited a distinct morphology resembling gastric glands, although 2 exceptional cases exhibited HPV-associated adenocarcinoma morphology while retaining the characteristic histology of GAS at the invasive front. By immunohistochemistry, Claudin18.2 emerged as a highly sensitive and specific marker for GAS. Additionally, the strong expression of Claudin18.2 in patients with GAS indicated the potential of anti-Claudin18.2 therapy in the treatment of GAS. Other immunohistochemistry markers, including Muc6, p16, p53, Pax8, ER, and PR, may provide additional diagnostic clues for GAS. Quantitative methylation analysis revealed that the overexpression of Claudin18.2 in GAS was governed by the hypomethylation of the CLDN18.2 promoter CpG islands. To further elucidate the pathogenic mechanisms of GAS and its relationship with gastric adenocarcinoma, we performed whole exome sequencing on 11 GAS and 9 gastric adenocarcinomas. TP53, CDKN2A, STK11, and TTN emerged as the most frequently mutated genes in GAS. Mutations in these genes primarily affected cell growth, cell cycle regulation, senescence, and apoptosis. Intriguingly, these top mutated genes in GAS were also commonly mutated in gastric and pancreaticobiliary adenocarcinomas. Regarding germline variants, we identified a probably pathogenic variant in SPINK1, a gene linked to hereditary pancreatic cancer syndrome, in one GAS sample. This finding suggests a potential pathogenic link between pancreatic cancers and GAS. Overall, GAS exhibits molecular characteristics that resemble those observed in gastric and pancreaticobiliary adenocarcinomas, thereby lending support to the aggressive nature of GAS compared with HPV-associated adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorClaudinsUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedAdenocarcinomaAdenocarcinoma, MucinousDNA MethylationImmunohistochemistry

Stichwörter der Autor:innen

Claudin18.2diagnosisendocervical gastric-type adenocarcinomatargeted therapy

Substanzen

Biomarkers, TumorClaudinsCLDN18 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Fourth Department of Gynecologic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Pathology, Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. Electronic address: congrong_liu@hsc.pku.edu.cn.

Förderung

  • Hunan Provincial Natural Science Foundation
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Peking University Third Hospital

Zitieren

APA

Yang, J., Peng, Y., Ding, Y., Liu, Y., Wang, Y., Liu, Y., & Liu, C. (2024). The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target. Modern Pathology, 37(10), 100569. https://doi.org/10.1016/j.modpat.2024.100569

Vancouver

Yang J, Peng Y, Ding Y, Liu Y, Wang Y, Liu Y, et al. The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target. Modern Pathology. 2024;37(10):100569. doi:10.1016/j.modpat.2024.100569

BibTeX
@article{Yang2024,
  author = {Yang, Jing and Peng, Yang and Ding, Yan and Liu, Yueping and Wang, Yuxiang and Liu, Yan and Liu, Congrong},
  title = {The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {10},
  pages = {100569},
  doi = {10.1016/j.modpat.2024.100569}
}
Kostenlos starten →